Hydrocodone Bitartrate And Acetaminophen
Product Images NDC 67296-1791

8 FDA label images from Redpharm Drug, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Hydrocodone Bitartrate And Acetaminophen (NDC 67296-1791). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Epm Label (67296 1791)

Epm Label (67296 1791)
Three pharmaceutical labels for Hydrocodone Bitartrate and Acetaminophen 5/325 mg tablets by RedPharm Drug, Inc. Each label shows different package sizes: 50 tablets, 12 tablets, and 60 tablets. Labels include lot numbers, expiration date 08/23, manufacturing by Aurobindo Pharma Inc, Dayton NJ, and storage instructions. Each label includes barcodes and a control symbol.*
FDA Label Image

67296 1791 1

67296 1791 1
Label for Hydrocodone Bitartrate and Acetaminophen tablets containing 5 mg/325 mg strength. The label indicates a package of 10 tablets, Rx only, with lot number 9014A1X5 and expiration date 10/22. Manufactured by Aurobindo Pharma Inc, Dayton NJ, and distributed by Redpharm Drug, Eden Prairie, MN. Storage instructions specify controlled room temperature of 20-25°C (68-77°F).*
FDA Label Image

Epm Label (67296 1791)

Epm Label (67296 1791)
Labels for Hydrocodone Bitartrate and Acetaminophen 5/325MG tablets distributed by RedPharm Drug, Inc. Each label indicates prescription-only status and lists package sizes of 6, 15, 20, and 30 tablets. The manufacturer is Aurobindo Pharma Inc, Dayton, NJ. Storage conditions and expiration date of 10/22 are also noted.*
FDA Label Image

Hbtapap10mg100ct (Hbtapap10mg100ct)

Hbtapap10mg100ct (Hbtapap10mg100ct)
Packaging label for Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/325 mg by Aurobindo Pharma USA, Inc. The label indicates 100 tablets per package and includes storage instructions, distribution details, and warnings. The label prominently displays the dosage strength and the Aurobindo logo.*
FDA Label Image

Hbtapap5mg100ct (Hbtapap5mg100ct)

Hbtapap5mg100ct (Hbtapap5mg100ct)
Packaging label for Hydrocodone Bitartrate and Acetaminophen Tablets, USP 5 mg/325 mg, distributed by Aurobindo Pharma USA, Inc. The label indicates the product contains 100 tablets and includes storage instructions, pharmacy dispensing requirements, and a barcode. The label also features the Aurobindo logo and prescribing information notes.*
FDA Label Image

Hbtapap7.5mg100ct (Hbtapap7.5mg100ct)

Hbtapap7.5mg100ct (Hbtapap7.5mg100ct)
Label for Hydrocodone Bitartrate and Acetaminophen Tablets, USP 7.5 mg/325 mg, distributed by Aurobindo Pharma USA, Inc. The label indicates 100 tablets per container, storage instructions at 20° to 25°C, pharmacist dispensing requirements, and dosage information referencing the package insert. The label includes a barcode and the product NDC 13107-020-01.*
FDA Label Image

Chemical Structure (Hydrocodone Str1)

Chemical Structure (Hydrocodone Str1)
Chemical structure of Hydrocodone Bitartrate and Acetaminophen depicting the molecular formula C18H21NO3•C4H6O6•2 1/2H2O with a molecular weight of 494.49. The diagram shows detailed atomic connectivity and arrangement.*
FDA Label Image

Chemical Structure (Hydrocodone Str2)

Chemical Structure (Hydrocodone Str2)
Chemical structure of Acetaminophen, showing its molecular formula C8H9NO2 and molecular weight 151.16. The diagram depicts the aromatic ring with hydroxyl and amide functional groups attached.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.